Helix BioPharma Corp.

TSX Exchange | Aug 19, 2019, 3:21 PM EDT | Real-time price

HBP $ 0.73 RT
-0.02 (-2.67%)
Day Low: 0.72
Day High: 0.75
Detailed Quote
Open: 0.75
High: 0.75
Beta: 0.365
Shares Out.: 111,225,501
Total Shares (All Classes): 111,225,500
Prev. Close: 0.75
Low: 0.72
VWAP: 0.733333
Market Cap: 81,194,616
Market Cap (All Classes)*: 81,194,615
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.07
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -36.500
Exchange: TSX
*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its drug product candidates are L-DOS47, V-DOS47.The company has Tumor defense breakers and Tumor defense attackers product candidates in the pipeline. More

News Headlines for Helix BioPharma Corp.
News Headlines for Helix BioPharma Corp.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.